Does CAPLACIZUMAB-YHDP Cause Haemoglobin abnormal? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Haemoglobin abnormal have been filed in association with CAPLACIZUMAB-YHDP. This represents 1.2% of all adverse event reports for CAPLACIZUMAB-YHDP.
16
Reports of Haemoglobin abnormal with CAPLACIZUMAB-YHDP
1.2%
of all CAPLACIZUMAB-YHDP reports
0
Deaths
4
Hospitalizations
How Dangerous Is Haemoglobin abnormal From CAPLACIZUMAB-YHDP?
Of the 16 reports, 4 (25.0%) required hospitalization.
Is Haemoglobin abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Off label use (133)
Platelet count decreased (126)
Epistaxis (123)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
What Other Drugs Cause Haemoglobin abnormal?
RUXOLITINIB (500)
ECULIZUMAB (466)
VENETOCLAX (248)
DARBEPOETIN ALFA (213)
ADALIMUMAB (207)
LENALIDOMIDE (172)
RITUXIMAB (157)
ERYTHROPOIETIN (154)
IBRUTINIB (148)
DEXAMETHASONE (147)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Haemoglobin abnormal Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE